Oral ganciclovir as maintenance treatment for AIDS-related cytomegalovirus retinitis following induction therapy;Ganciclovir oral en traitement de relais de la retinite a CMV

Medecine et Maladies Infectieuses

Volumn 27, Issue 5, 1997, Pages 617-618

  Raffi, F ^a  

^a HÔTEL DIEU   (France)

Author keywords

Cytomegalovirus retinitis; Foscarnet; Maintenance therapy; Oral ganciclovir

Indexed keywords

FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG CHOICE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; OPHTHALMOSCOPY; ORAL DRUG ADMINISTRATION; RETINITIS; RISK BENEFIT ANALYSIS;

EID: 0030837550     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(97)80095-9     Document Type: Letter

References (15)

1. Studies of Ocular Complications of AIDS Research Group, in Collaboration with the AIDS Clinical Trials Group - Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992; 326: 213-20.
2. MARKHAM A., FAULDS D. - Ganciclovir, an update of its therapeutic use in cytomegalovirus infection. Drugs. 1994; 48: 455-84.
3. BRETON G., CRÉMIEUX A.C. - Le traitement des infections à cytomegalovirus au cours de l'infection à VIH. Presse Méd. 1996; 25: 1967-73.
4. RAFFI F. - Infections à cytomégalovirus au cours du SIDA. Rev Prat. 1995; 45: 733-8.
5. SOCA. - Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch Intern Med. 1995; 155: 65-73.
6. DREW W.L., IVES D., LALEZARI J.P., CRUMPACKER C., FOLLANSBEE S.E., SPECTOR S.A., BENSON C.A., FRIEDBERG D.N., HUBBARD L., STEMPIEN M.J., SHADMAN A., BUHLES W. - Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med. 1995; 333: 615-20.
7. COCHEREAU-MASSIN I., LEHOANG P., LAUTIER-FRAU M., ZAZOUN L., MARCEL P., ROBINET M., MATHERON S., KATLAMA C., GHARAKHANIAN S., ROZENBAUM W., INGRAND D., GENTILINI M. - Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophtalmology. 1991; 98: 1348-55.
8. DROUET E., BOIBIEUX A., MICHELSON S., ECOCHARD R., BIRON F., PEYRAMOND D., COLIMON R., DENOYEL G. - Polymerase chain reaction detection of cytomegalovirus DNA in peripheral blood leukocytes as a predictor of cytomegalovirus disease in HIV-infected patients. AIDS. 1993; 7: 665-8.
9. REYNES J., MONTES B., AOUTTI N., SEGONDY M. - Significance of cytomegalovirus-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients. J Med Virol. 1996; 49: 195-8.
10. DANNER S.A. - Management of cytomegalovirus disease. AIDS. 1995; 9 (suppl. 2): S3-8.
11. HOLLAND G.N., LEVINSON R.D., JACOBSON M.A. - Dose-related difference in progression rates of CMV retinopathy during foscarnet maintenance therapy. Am J Ophtalmol. 1995; 119: 576-86.
12. SMITH I.L., FLORES-AGUILAR M., TASKITUNA I., JILES R.E., FREEMAN W.R., SPECTOR S.A. - Cytomegalovirus resistance is associated with clinical failure in AIDS patients receiving ganciclovir treatment for retinitis. In "Program and abstracts of the 36th ICAAC". 1996; New-Orleans, H30.
13. BUHLES W., DREW W.L., MINOR D. - Cytomegalovirus resistance rates following treatment with IV and oral ganciclovir. In Program and abstracts of the 34th ICAAC. 1994; Orlando, H30.
14. The Oral Ganciclovir Europan and Australian Cooperative Study Group - Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis in patients with AIDS. AIDS. 1995; 9: 471-7.
15. GRAF VON DEN SCHULENBURG J.M., WÄHLING S., STOLL M. German health economic cost evaluation on oral ganciclovir in treating cytomegalovirus retinitis. Pharmacoeconomics. 1996; 10: 522-30.